Viro Lec - Part 1 Module 3 - Last part Flashcards

1
Q

Activates the signaling cascade → resulting to induction of the interferon response genes in cells

A

Type 1 interferon (IFN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cytokine central to both innate and adaptive immunity

A

Type II interferon or IFN-γ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Example of PAMPS

A
  1. Nucleic acids (viruses)
  2. Surface lipoprotein (viruses)
  3. Lipoprotein (bacteria)
  4. Capsule (bacteria)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Binding of PAMPs to PRRs stimulates?

A

transcription of numerous genes encoding proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

class of PRRs

A

Toll-like receptors (TLRs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TLRs bind ssRNA, detect RNA virus infections

A

TLR7 & TLR8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TLRs detects dsRNA

A

TLR3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Specialized lymphocytes; Lack an antigen-specific receptor (but can recognize PAMPS)

A

Natural Killer Cells (NK cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Increased MHC1 means?

A

will indicate a not stressed cell → The NK cell will detect → NK will initiate inhibitory signal → therefore no apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Decreased MHC 1 means?

A

→ will indicate an infected/ stressed cell → NK will detect it → it will make the cell undergo apoptosis → the cell will die → therefore there is no replication and it will eliminate the virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NK cells have two types of receptors

A

○ Activating receptors (detect stress signals).
○ Inhibiting receptors (detect normal proteins like MHC molecules).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NK cells release granules containing:

A

Perforin & Granzymes (A & B):

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Forms pores in the target cell membrane.

A

Perforin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Enter through the pores to trigger cell death.

A

Granzymes (A & B)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mediated by antibodies secreted by terminally differentiated lymphocytes called plasma cells

A

Humoral immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

driven by cell receptors expressing lymphocytes

A

Cell-mediated immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

when activated by infected cell, it will produce cytokines

A

T- Helper Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

will directly and cause apoptosis of infected cell

A

Cytotoxic T Lymphocytes

19
Q

Processes antigens from intracellular sources

A

Class I MHC Pathway (Cytosolic Pathway)

20
Q

Processes antigens from extracellular sources

A

Class II MHC Pathway (Endocytic Pathway)

21
Q

Cytosolic Pathway is recognized by?

A

CD8+ Cytotoxic T cells

22
Q

Endocytic Pathway is recognized by?

A

CD4+ Helper T cells

23
Q

Antibody found primarily in blood; first antibodies produced

24
Q

Antibody principal class of Ab in blood and extracellular fluid

25
Q

Antibody main antibody in secretions in respiratory, genital and GIT

26
Q

Antibody very low conc. in blood and ECF; mediates allergic reactions

27
Q

Antibody expressed almost exclusively as a cell surface molecule by naïve B cells

28
Q

Types of Vaccines

A

● Live-attenuated virus vaccines
● Non-replicating virus vaccines
● Vaccines Produced Using Recombinant DNA and Related Technologies

29
Q

Vaccines that elicits a lasting immune response while causing little or no disease; mimics a subclinical infection

A

Live-attenuated virus vaccines

30
Q

Vaccines usually made from virulent viruses that are killed through chemical or physical agents but still maintain immunogenicity

A

Inactivated (Killed) Whole Virions

31
Q

Vaccines that use lipid solvents (e.g. sodium deoxycholate) in enveloped viruses to solubilize the virion and release the components

A

Purified Native Viral Proteins

32
Q

Deliberate insertion of several attenuating mutations into key viral genes or completely deleting nonessential genes that contribute to virulence

A

Attenuation of Viruses by Gene Deletion or Site-Directed Mutagenesis

33
Q

Utilizes eukaryotic expression vectors such as plant and yeast cells, insect cells and various mammalian cells

A

Subunit vaccines produced by expression of viral proteins

34
Q

Some nonenveloped icosahedral viruses have capsid proteins that self- assemble into virus-like particles (VLPs)

A

Viral Proteins that Self-Assemble into virus-like particles (VLPs)

35
Q

Recombinant DNA techniques enable the insertion of foreign genes into viral genomes.

A

Viruses as vectors for Expression of Heterologous Viral Antigens

36
Q

A type of vaccine that uses a bacterial plasmid to introduce DNA sequence (encoding an antigen) into an individual’s cells

A

DNA vaccines

37
Q

measures only one limb of the adaptive immune response which is the humoral immunity

A

(Serological Diagnosis)

38
Q

sample of choice for serological assays

39
Q

assays of choice for the qualitative or quantitative determination of viral antibodies; rapid, relatively cost-effective

A

Enzyme Immunoassay – Enzyme-linked Immunosorbent Assay (ELISA)

40
Q

the gold standard for the detection and quantitation of virus-specific antibodies; the binding of antibody to infectious virus, thus preventing the virus from initiating
an infection in a susceptible cell

A

Serum (Virus) Neutralization Assay

41
Q

simultaneously but independently measure antibodies against several proteins of the agent of interest

A

Immunoblotting (Western blotting)

42
Q

widely used for viruses (e.g. influenza, parainfluenza) that hemagglutinate red blood cells of one or another species

A

Hemagglutination-Inhibition Assay